U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula 2C9H13NO.C4H6O6
Molecular Weight 452.4981
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 4
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GEPEFRINE HEMITARTRATE

SMILES

O[C@H]([C@@H](O)C(O)=O)C(O)=O.C[C@H](N)CC1=CC(O)=CC=C1.C[C@H](N)CC2=CC(O)=CC=C2

InChI

InChIKey=UATCOBHGDOXJOR-QELAQPMUSA-N
InChI=1S/2C9H13NO.C4H6O6/c2*1-7(10)5-8-3-2-4-9(11)6-8;5-1(3(7)8)2(6)4(9)10/h2*2-4,6-7,11H,5,10H2,1H3;1-2,5-6H,(H,7,8)(H,9,10)/t2*7-;1-,2-/m001/s1

HIDE SMILES / InChI
Gepefrine (Pressionorm and Wintonin) is an antihypotensive agent. It was used for therapy of orthostatic dysregulation. One hour after oral administration of 30 mg or 45 mg gepefrine the blood pressure increased significantly at rest and more markedly on standing and during the step test. Gepefrine led to a reduction in pathological orthostatic regulation during the early phase as well as to the prevention of subjective and objective signs of orthostatic adjustment disorder during the late phase. Patients with insufficient rise in blood pressure during the step test (80 watts) showed after gepefrine a distinct tendency towards normalisation and the regression of subjective states of exhaustion. Gepefrine caused on average no substantive alternations in heart rate during all phases of the investigation. Complications or side-effects due to the method or the medicament were not observed.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
PubMed

PubMed

TitleDatePubMed
[Therapy of orthostatic dysregulation with gepefrin. Study with continuous telemetric blood pressure monitoring].
1985 Apr
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: The action of the pressor agent gepefrine (D form of 3-hydroxyphenyl-2-aminopropan) was evaluated in 16 patients with typical clinical symptoms of orthostatic adjustment disorders
One hour after oral administration of 30 mg or 45 mg gepefrine the blood pressure increased significantly at rest and more markedly on standing and during the step test.
Route of Administration: Oral
Name Type Language
GEPEFRINE HEMITARTRATE
Common Name English
Gepefrine bitartrate [WHO-DD]
Common Name English
PHENOL, 3-(2-AMINOPROPYL)-, (S)-, (R-(R*,R*))-2,3-DIHYDROXYBUTANEDIOATE (2:1) (SALT)
Systematic Name English
PHENOL, 3-(2-AMINOPROPYL)-, (S)-, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE (2:1) (SALT)
Systematic Name English
GEPEFRINE BITARTRATE
WHO-DD  
Common Name English
Code System Code Type Description
FDA UNII
44IU6M2R49
Created by admin on Sat Dec 16 08:10:40 GMT 2023 , Edited by admin on Sat Dec 16 08:10:40 GMT 2023
PRIMARY
CAS
66068-90-4
Created by admin on Sat Dec 16 08:10:40 GMT 2023 , Edited by admin on Sat Dec 16 08:10:40 GMT 2023
PRIMARY
EVMPD
SUB02331MIG
Created by admin on Sat Dec 16 08:10:40 GMT 2023 , Edited by admin on Sat Dec 16 08:10:40 GMT 2023
PRIMARY
EPA CompTox
DTXSID50216270
Created by admin on Sat Dec 16 08:10:40 GMT 2023 , Edited by admin on Sat Dec 16 08:10:40 GMT 2023
PRIMARY
PUBCHEM
90479569
Created by admin on Sat Dec 16 08:10:40 GMT 2023 , Edited by admin on Sat Dec 16 08:10:40 GMT 2023
PRIMARY
SMS_ID
100000087257
Created by admin on Sat Dec 16 08:10:40 GMT 2023 , Edited by admin on Sat Dec 16 08:10:40 GMT 2023
PRIMARY